Bloodless Glucose Monitors
|出版商||Greystone Research Associates||商品編碼||345953|
The convergence of small-scale electronics and sophisticated biocompatible product designs is creating the prospect of bloodless glucose monitoring for patients diagnosed with diabetes. Bloodless glucose monitors that can measure glucose levels accurately and reliably have the capability to improve glycemic control and patient wellbeing. By integrating the sensing element, electronics, and a power source in a single package, noninvasive monitors are creating new options for caregivers and their diabetes patients. Signal processing improvements - include improved signal-to-noise ratios and interference filtering - will continue to be critical to the commercialization prospects of noninvasive monitors. While the potential is substantial, for most participants the road to commercialization will be rocky due to capitalization requirements and the need for investor patience. Successful players will be those that can form partnerships and strategic alliances
A longer life span is expected to translate to a growing number of patients diagnosed with chronic conditions. To counteract the financial and medical infrastructure implications of this trend, pressure from the public sector and managed care organizations will place a premium on therapeutic self-administration, an expectation that is creating an increased interest in routes of administration that are patient-friendly and cost-effective. Pharma company decision makers have come to the realization that for many products, success no longer only depends on the medication itself but also on achieving a consumer-compatible form of packaging and application.
‘Traditional monitoring and insulin administration techniques require diabetes patients to carry glucose testing and insulin administration paraphernalia with them when they leave home and to prick themselves numerous times during the course of the day. These activities are seen as restrictive and socially and physically uncomfortable by most insulin-dependent diabetics, and can result in less-than-optimal compliance in management schedules. For adolescent patients, aversion to needle sticks is a real issue that must be dealt with by children and parents.'
Our reports are carefully researched and written to provide timely and insightful analysis of key factors and developments shaping the commercial marketplace. The focused nature of our publications is designed to allow readers to identify emerging demand and growth opportunities in selected markets. Numerous charts, tables and graphs complement the text, with evaluations and assessments of current and probable future market developments, technology issues and business factors - information necessary to compete effectively in the global marketplace.